海湾与中东 · 区域市场 · Globes
Teva again raises guidance as branded drugs lift revenue
Revenue in the third quarter was $4.4 billion, while analysts had predicted $4.2 billion and non-GAAP earnings per share was $0.86, well above the analysts’ consensus of $0.72.
在 Globes 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (en.globes.co.il)
